Varian, Agilent Extend Date of Expected Merger Completion | GenomeWeb

NEW YORK (GenomeWeb News) – Varian has provided Agilent Technologies with a written notice that it has extended the "end date" for their merger agreement 90 days to April 26, 2010.

Varian disclosed the extension in a US Securities and Exchange Commission filing last week. It said that the deal is still subject to regulatory approvals and other closing conditions.

Agilent signed a definitive agreement to acquire Varian for $52 per share, or a total of around $1.5 billion, back in July.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.